Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults.
Clinical trial NCT05490108 · UNKNOWN
Trial details
- NCT number
- NCT05490108
- Sponsor
- Shanghai Zerun Biotechnology Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-02
- Primary completion
- 2022-09-26
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.